Literature DB >> 21310912

Fundus autofluorescence and spectral-domain optical coherence tomography characteristics in a rapidly progressing form of geographic atrophy.

Monika Fleckenstein1, Steffen Schmitz-Valckenberg, Christine Martens, Sebastian Kosanetzky, Christian K Brinkmann, Gregory S Hageman, Frank G Holz.   

Abstract

PURPOSE: To further characterize a previously described phenotypic variant of geographic atrophy (GA) associated with rapid progression and a diffuse-trickling appearance on fundus autofluorescence (FAF).
METHODS: Thirty-six patients (60 eyes; 72.2% women; mean age, 69.4 ± 10.7 years) with this distinct phenotype were examined by simultaneous confocal scanning laser ophthalmoscopy (cSLO) and spectral-domain optical coherence tomography (SD-OCT) imaging. Images were qualitatively and quantitatively analyzed and compared with 60 eyes (38 patients) with non diffuse-trickling GA.
RESULTS: The atrophic area in the diffuse-trickling phenotype showed a grayish FAF signal and characteristic coalescent lobular configuration at the lesion boundaries. SD-OCT revealed a marked splitting of band 4 (the presumptive retinal pigment epithelium (RPE)/Bruch's membrane (BM) complex) in all 240 analyzed border sections of diffuse-trickling GA eyes (four borders/eye) with a mean distance between the inner and outer parts of band 4 of 23.2 ± 7.5 μm. This finding was present in only 13.8% (33/240) of analyzed border sections in non diffuse-trickling GA.
CONCLUSIONS: Patients with the rapidly progressing diffuse-trickling GA phenotype exhibited a characteristic marked separation within the RPE/BM complex on SD-OCT-imaging. The presumed histopathologic correlates are basal laminar deposits. Such deposits may promote RPE cell death and, thus, contribute to rapid GA progression. The persistence of these deposits within the atrophic lesion may account for the distinct grayish FAF appearance, which differs from the markedly reduced signal in other forms of GA. Identification of such alterations based on FAF and SD-OCT imaging may be helpful in future interventional trials directed toward slowing GA progression. (ClinicalTrials.gov number, NCT00393692.).

Entities:  

Mesh:

Year:  2011        PMID: 21310912      PMCID: PMC3109052          DOI: 10.1167/iovs.10-7021

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  37 in total

1.  Evolution of geographic atrophy of the retinal pigment epithelium.

Authors:  J P Sarks; S H Sarks; M C Killingsworth
Journal:  Eye (Lond)       Date:  1988       Impact factor: 3.775

2.  The effect of age on the macromolecular permeability of human Bruch's membrane.

Authors:  D J Moore; G M Clover
Journal:  Invest Ophthalmol Vis Sci       Date:  2001-11       Impact factor: 4.799

Review 3.  [Therapy approaches for geographic atrophy].

Authors:  S Schmitz-Valckenberg; A Mössner; M Fleckenstein; P Wiedemann; F G Holz
Journal:  Ophthalmologe       Date:  2010-11       Impact factor: 1.059

Review 4.  Age-related macular degeneration--emerging pathogenetic and therapeutic concepts.

Authors:  Karen M Gehrs; Don H Anderson; Lincoln V Johnson; Gregory S Hageman
Journal:  Ann Med       Date:  2006       Impact factor: 4.709

5.  Human macula investigated in vivo with polarization-sensitive optical coherence tomography.

Authors:  Michael Pircher; Erich Götzinger; Oliver Findl; Stephan Michels; Wolfgang Geitzenauer; Christina Leydolt; Ursula Schmidt-Erfurth; Christoph K Hitzenberger
Journal:  Invest Ophthalmol Vis Sci       Date:  2006-12       Impact factor: 4.799

Review 6.  The pivotal role of the complement system in aging and age-related macular degeneration: hypothesis re-visited.

Authors:  Don H Anderson; Monte J Radeke; Natasha B Gallo; Ethan A Chapin; Patrick T Johnson; Christy R Curletti; Lisa S Hancox; Jane Hu; Jessica N Ebright; Goldis Malek; Michael A Hauser; Catherine Bowes Rickman; Dean Bok; Gregory S Hageman; Lincoln V Johnson
Journal:  Prog Retin Eye Res       Date:  2009-12-02       Impact factor: 21.198

Review 7.  New era for personalized medicine: the diagnosis and management of age-related macular degeneration.

Authors:  Paul N Baird; Gregory S Hageman; Robyn H Guymer
Journal:  Clin Exp Ophthalmol       Date:  2009-11       Impact factor: 4.207

8.  Spectral domain optical coherence tomography imaging of geographic atrophy margins.

Authors:  Srilaxmi Bearelly; Felix Y Chau; Anjum Koreishi; Sandra S Stinnett; Joseph A Izatt; Cynthia A Toth
Journal:  Ophthalmology       Date:  2009-07-29       Impact factor: 12.079

9.  Central areolar choroidal dystrophy.

Authors:  Camiel J F Boon; B Jeroen Klevering; Frans P M Cremers; Marijke N Zonneveld-Vrieling; Thomas Theelen; Anneke I Den Hollander; Carel B Hoyng
Journal:  Ophthalmology       Date:  2009-02-25       Impact factor: 12.079

10.  Correlation between spectral-domain optical coherence tomography and fundus autofluorescence at the margins of geographic atrophy.

Authors:  Manpreet Brar; Igor Kozak; Lingyun Cheng; Dirk-Uwe G Bartsch; Ritchie Yuson; Nitin Nigam; Stephen F Oster; Francesca Mojana; William R Freeman
Journal:  Am J Ophthalmol       Date:  2009-07-09       Impact factor: 5.258

View more
  19 in total

1.  Late-onset night blindness with peripheral flecks accompanied by progressive trickle-like macular degeneration.

Authors:  Kazushige Tsunoda; Kaoru Fujinami; Kazutoshi Yoshitake; Takeshi Iwata
Journal:  Doc Ophthalmol       Date:  2019-07-08       Impact factor: 2.379

2.  The Project MACULA Retinal Pigment Epithelium Grading System for Histology and Optical Coherence Tomography in Age-Related Macular Degeneration.

Authors:  Emma C Zanzottera; Jeffrey D Messinger; Thomas Ach; R Theodore Smith; K Bailey Freund; Christine A Curcio
Journal:  Invest Ophthalmol Vis Sci       Date:  2015-05       Impact factor: 4.799

3.  OCT minimum intensity as a predictor of geographic atrophy enlargement.

Authors:  Paul F Stetson; Zohar Yehoshua; Carlos Alexandre A Garcia Filho; Renata Portella Nunes; Giovanni Gregori; Philip J Rosenfeld
Journal:  Invest Ophthalmol Vis Sci       Date:  2014-02-10       Impact factor: 4.799

4.  Progression of Unifocal versus Multifocal Geographic Atrophy in Age-Related Macular Degeneration: A Systematic Review and Meta-analysis.

Authors:  Liangbo L Shen; Mengyuan Sun; Holly K Grossetta Nardini; Lucian V Del Priore
Journal:  Ophthalmol Retina       Date:  2020-04-04

Review 5.  Lessons learned from quantitative fundus autofluorescence.

Authors:  Janet R Sparrow; Tobias Duncker; Kaspar Schuerch; Maarjaliis Paavo; Jose Ronaldo Lima de Carvalho
Journal:  Prog Retin Eye Res       Date:  2019-08-28       Impact factor: 21.198

Review 6.  A view of the current and future role of optical coherence tomography in the management of age-related macular degeneration.

Authors:  U Schmidt-Erfurth; S Klimscha; S M Waldstein; H Bogunović
Journal:  Eye (Lond)       Date:  2016-11-25       Impact factor: 3.775

Review 7.  Perspectives from clinical trials: is geographic atrophy one disease?

Authors:  Sobha Sivaprasad; Shruti Chandra; Jeha Kwon; Noorulain Khalid; Victor Chong
Journal:  Eye (Lond)       Date:  2022-05-31       Impact factor: 3.775

8.  The Evolution of the Plateau, an Optical Coherence Tomography Signature Seen in Geographic Atrophy.

Authors:  Anna C S Tan; Polina Astroz; Kunal K Dansingani; Jason S Slakter; Lawrence A Yannuzzi; Christine A Curcio; K Bailey Freund
Journal:  Invest Ophthalmol Vis Sci       Date:  2017-04-01       Impact factor: 4.799

9.  Histologic basis of variations in retinal pigment epithelium autofluorescence in eyes with geographic atrophy.

Authors:  Martin Rudolf; Susan D Vogt; Christine A Curcio; Carrie Huisingh; Gerald McGwin; Anna Wagner; Salvatore Grisanti; Russell W Read
Journal:  Ophthalmology       Date:  2013-01-26       Impact factor: 12.079

10.  Restricted Summed-Area Projection for Geographic Atrophy Visualization in SD-OCT Images.

Authors:  Qiang Chen; Sijie Niu; Honglie Shen; Theodore Leng; Luis de Sisternes; Daniel L Rubin
Journal:  Transl Vis Sci Technol       Date:  2015-09-01       Impact factor: 3.283

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.